SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001396814-23-000085
Filing Date
2023-12-21
Accepted
2023-12-21 07:33:59
Documents
16
Period of Report
2023-12-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20231220.htm   iXBRL 8-K 39798
2 EX-10.1 ex101-frankleecontract.htm EX-10.1 97283
3 EX-10.2 ex102-ar2014inducementplan.htm EX-10.2 89560
4 EX-99.1 exhibit991-newceopr.htm EX-99.1 35799
8 PACIRA BIOSCIENCES LOGO pacirabiosciencesa01.jpg GRAPHIC 27796
  Complete submission text file 0001396814-23-000085.txt   482398

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20231220.xsd EX-101.SCH 1911
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20231220_lab.xml EX-101.LAB 25123
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20231220_pre.xml EX-101.PRE 13050
10 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20231220_htm.xml XML 2830
Mailing Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 231502779
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)